Rate My Professor John Terry

Professor John Terry FMedSci is an EPSRC Established Career Fellow and Professor of Digital Health Innovation in the Peninsula Medical School, Faculty of Health, at the University of Plymouth. He earned a PhD in Applied Mathematics from the University of Surrey in 2000 and a BSc (Hons) in Mathematics from the University of Reading in 1997. His career includes roles as Professor of Biomedical Modelling and Associate Director of the Living Systems Institute at the University of Exeter, followed by Interdisciplinary Professorial Fellow and Founding Director of the Centre for Systems Modelling and Quantitative Biomedicine at the University of Birmingham. Elected a Fellow of the Academy of Medical Sciences in 2025, he has secured research funding exceeding £35 million from sources including EPSRC, MRC, BBSRC, Innovate UK, NIHR, and Wellcome Trust. With over 80 peer-reviewed publications and more than 5,750 citations, his work has secured regulatory approval for NHS implementation and holds one patent with another pending.

John Terry's research focuses on mathematical modelling, machine learning, and neuroscience, particularly digital biomarkers for epilepsy diagnosis using EEG data. As Co-Founder and Managing Director of Neuronostics since 2018, he developed BioEP™, addressing the 70% of inconclusive EEG tests in suspected epilepsy cases; the company has raised over £5 million in grants and equity. He is also Co-Founder of Hazelmoor Consultancy since 2024 and Theme Lead for Enabling Technologies at the Epilepsy Research Institute UK from 2025 to 2028. Key publications include 'Prioritising follow-up for people with suspected epilepsy using a digital EEG biomarker' (Shankar & Terry, 2026, Epilepsy and Behavior), 'The future of epilepsy care in the United Kingdom: A roadmap for technology-enabled transformation' (Shankar & Terry, 2026, Epilepsia Open), 'British academic psychiatry at a crossroads: lessons from the past 20 years and priorities for the next 20 years' (Shankar et al., 2025, International Review of Psychiatry), and 'Associating EEG functional networks and the effect of sleep deprivation as measured using psychomotor vigilance tests' (Mason et al., 2024, Scientific Reports). Awards include TechSpark Founder of the Year (2024), $125,000 Epilepsy Foundation Shark Tank competition win (2024), and EPSRC Public Engagement Champion (2023-2025). He has co-created the theatrical production 'Beyond My Control' and established an artist-in-residency programme, contributing to SDG 3 (Good Health and Well-being) and SDG 9 (Industry, Innovation, and Infrastructure).